10-Q: Envirotech Vehicles Q1 2026: Revenue Up, Net Loss Widens

Envirotech Vehicles reports a significant increase in Q1 2026 revenue driven by its medical supplies segment, though net loss also widened due to operational costs and financial adjustments.

Summary

• Envirotech Vehicles reported Q1 2026 sales of $2,248,621, a substantial increase from $590,567 in Q1 2025, primarily driven by its medical supplies segment.
• The company experienced a net loss of $3,986,923 for Q1 2026, compared to a net loss of $14,036,381 for Q1 2025. This widening loss is attributed to increased cost of sales and operating expenses, including a significant goodwill impairment charge in the prior year's quarter.
• Cash used in operating activities was $3,342,098 for Q1 2026, an improvement from $4,217,480 in Q1 2025, indicating some operational efficiency gains.
• Financing activities provided $6,522,849 in net cash for Q1 2026, mainly from the issuance of common stock and debentures, which is crucial for ongoing operations.
• The company continues to face substantial doubt regarding its ability to continue as a going concern due to sustained losses and negative cash flows, despite recent financing efforts.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the widening net loss, negative gross profit, and the continued going concern warning, despite revenue growth in one segment.

Positives

• Significant revenue growth, with sales increasing from $590,567 in Q1 2025 to $2,248,621 in Q1 2026, largely due to the medical supplies segment.
• Reduced cash used in operating activities, decreasing from $4,217,480 in Q1 2025 to $3,342,098 in Q1 2026.
• Successful capital raises through debt and equity financing, providing essential liquidity.
• The company's medical supplies segment generated $2,248,621 in revenue in Q1 2026, demonstrating a successful diversification.
• Common stock outstanding increased from 7,736,129 as of December 31, 2025, to 12,930,719 as of March 31, 2026, indicating equity financing.

Negatives

• Net loss widened to $3,986,923 in Q1 2026 from $14,036,381 in Q1 2025, despite the revenue increase, due to higher cost of sales and operating expenses.
• Gross profit turned negative at $(188,612) in Q1 2026, compared to a positive $119,392 in Q1 2025, indicating that cost of sales outpaced net sales.
• The company's electric vehicle segment reported $0 in sales for Q1 2026, a significant drop from $373,130 in Q1 2025.
• Accumulated deficit increased to $116,575,383 as of March 31, 2026, from $112,588,460 as of December 31, 2025.
• The company received a Nasdaq deficiency notice on April 29, 2026, for not meeting the minimum shareholders' equity requirement.

Risks

• The "One Big, Beautiful Bill Act" may adversely affect demand for vehicles due to reduced electric vehicle credits.
• Import tariffs could significantly impact vehicle demand or reduce gross profits if not passed on to customers.
• The company's ability to continue as a going concern is subject to substantial doubt due to sustained losses and negative cash flows.
• Dependence on external sources of financing for operations.
• Challenges in establishing a complete dealer and service network, including finding and training technicians with zero-emission electric fleet vehicle experience.
• Reliance on third-party contractors, suppliers, and manufacturers, including a sole vendor for vehicles manufactured in the United States.
• Potential impact of product recalls and product liability claims.
• Disruptions to global supply chains for raw materials, parts, and components.
• The company is involved in multiple ongoing legal proceedings, including claims of breach of fiduciary duty, misuse of confidential information, defamation, and extortion.

Future Outlook

The company plans to grow and expand its operations and seek additional sources of capital through debt or equity financing, and potentially pursue acquisitions of cash flow generating assets or businesses. However, there is no guarantee of successful financing or acquisitions. The company also anticipates increased operating expenses due to investments in R&D, manufacturing, sales, and marketing.

Management Comments

• Management believes that its future operating strategy will provide the opportunity to continue as a going concern as long as the Company is able to obtain additional financing; however, there is no assurance this will occur.
• We believe the market for all-electric solutions for alternative fuel technology, specifically all-electric vehicles, will continue to grow as more purchases of new zero-emission vehicles and as more conversions of existing fleet vehicles to zero-emission vehicles are made.
• We expect cash used in operating activities to fluctuate significantly in future periods as a result of a number of factors, some of which are outside of our control.

Industry Context

StockSavvy.ai notes that Envirotech Vehicles' Q1 2026 results reflect a challenging environment for electric vehicle manufacturers, with a significant decline in EV segment sales. The company's reliance on its medical supplies segment for revenue highlights a strategic pivot or diversification effort amidst broader industry shifts and economic pressures impacting the EV market.

Comparison to Industry Standards

• The negative gross profit margin in Q1 2026 is significantly below industry standards for established automotive manufacturers, which typically aim for healthy positive gross margins.
• The substantial net loss and ongoing cash burn are concerning when compared to profitable and cash-flow positive companies in the automotive and specialized vehicle sectors.
• The company's reliance on external financing and the "going concern" warning are critical indicators that differentiate it from more stable, mature industry players.
• While the medical supplies segment shows revenue growth, its contribution to overall profitability and its sustainability as a primary revenue driver compared to the core EV business needs further evaluation against industry benchmarks for diversified companies.

Legal Proceedings

• The Company is a defendant in litigation commenced by GreenPower Motor Company Inc. alleging breach of fiduciary duty, misuse of confidential information, unfair competition, and related matters.
• The Company sued Efraim Diveroli and Kingbird Ventures LLC for tortious interference with contract, tortious interference with prospective economic advantage, and defamation and business disparagement.
• The Company and Maddox Defense, Inc. sued Efraim Diveroli, Kingbird Ventures LLC, VD Acquisitions, LLC, Bront Bird, and Karla Mae Capital, LLC for civil extortion, RICO, fraudulent inducement, tortious interference, abuse of process, and unfair competition.
• VD Acquisitions LLC filed suit against Jason Maddox, Elgin Tracy, Maddox Defense, Maddox Industries, the Company, Phillip Oldridge, Karla Mae Capital, LLC and Airboss Defense Group, LLC for breach of contract, fraud in the inducement, fraudulent transfer, civil conspiracy, intentional interference with contract, and declaration of alter ego.
• The Company initiated legal proceedings against its former independent registered public accounting firm, MaloneBailey LLP, alleging breach of contract and related claims for failure to issue an audit report for the fiscal year ended December 31, 2022.

Related Party Transactions

• Lease agreements with SRI Professional Services, Incorporated (SRI) for equipment, where the CEO is an executive officer and board member of SRI.
• Commercial lease agreement with Alpha Bravo Charlie, Inc. (ABCI) for office space, where the CEO is a director of ABCI.
• Expenses to Shell Castle LLC and Met Consulting LLC for services rendered in lieu of wages, owned by President and Interim CFO (Jason Maddox) and COO (Elgin Tracy) respectively.
• All revenue from the medical supplies segment was from Maddox Medical Corp., owned by the President and Interim CFO, based on a contract fulfilled by a Company subsidiary.
• Procurement contract for electric vehicles and components with EVTV Canada, a related party where one of its officers holds significant shares in the Company.
• Sub-lease arrangement with Maddox Defense, an entity owned by the President and Interim CFO, for corporate and administrative operations.

Stakeholder Impact

• Shareholders: Dilution risk due to ongoing equity financing and conversion of debt instruments into common stock. Potential for share price volatility due to Nasdaq deficiency notice and going concern issues.
• Employees: Potential impact from restructuring activities and the need to attract and retain qualified personnel, especially in specialized areas like zero-emission vehicle technology.
• Creditors: Increased debt levels and the company's ability to service its debt obligations are key concerns.
• Customers: Potential impact from the "One Big, Beautiful Bill Act" and import tariffs on vehicle affordability and availability. The company is exploring leasing options to mitigate purchase cost barriers.
• Suppliers: The company relies on third-party suppliers, including a sole vendor for vehicles manufactured in the US, creating potential supply chain risks.

Next Steps

• The company plans to grow and expand its operations.
• Seeking additional sources of capital through debt or equity financing.
• Exploring acquisitions of cash flow generating assets or businesses.
• The company plans to close its Osceola, Arkansas facility in 2026.
• The initial pretrial and scheduling conference for the lawsuit against Efraim Diveroli and Kingbird Ventures LLC is set for May 28, 2026.

Key Dates

Recommendation

While the revenue growth in the medical supplies segment is positive, the company's core electric vehicle business is struggling, evidenced by zero sales in Q1 2026. The widening net loss, negative gross profit, ongoing legal proceedings, and the going concern warning, coupled with the Nasdaq deficiency notice, present significant risks. However, recent financing activities and the potential for future capital raises provide some liquidity. A 'hold' recommendation reflects a cautious approach, awaiting clearer signs of operational recovery in the EV segment and a resolution to the financial and legal challenges.

Keywords

Envirotech Vehicles, Form 10-Q, Quarterly Report, Electric Vehicles, Zero-Emission Vehicles, Medical Supplies, Drones, AI Infrastructure, Financial Statements, SEC Filing, Revenue, Net Loss, Going Concern